|
gptkbp:instanceOf
|
Person
|
|
gptkbp:advocacy
|
Public_Health_Initiatives
|
|
gptkbp:affiliation
|
gptkb:University_of_Alberta
|
|
gptkbp:almaMater
|
gptkb:University_of_Alberta
|
|
gptkbp:awards
|
Canada's_Top_40_Under_40
|
|
gptkbp:birthPlace
|
gptkb:Canada
|
|
gptkbp:class
|
International_Conferences
|
|
gptkbp:collaboratedWith
|
gptkb:Dr._Robert_Gallo
|
|
gptkbp:collaborations
|
International_Health_Organizations
|
|
gptkbp:conference
|
gptkb:Global_Health_Summit
|
|
gptkbp:contribution
|
Discovery_of_HIV-1
|
|
gptkbp:enrollment
|
PhD Students
|
|
gptkbp:field
|
Biochemistry
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Dr. Richard A. H. Houghton
|
|
gptkbp:influenced
|
HIV Research Community
|
|
gptkbp:influencedBy
|
gptkb:Louis_Pasteur
|
|
gptkbp:investmentFocus
|
gptkb:Journal_of_Virology
|
|
gptkbp:knownFor
|
Research on HIV
|
|
gptkbp:members
|
gptkb:Royal_Society_of_Canada
|
|
gptkbp:mentor
|
Young Scientists
|
|
gptkbp:nationality
|
Canadian
|
|
gptkbp:patentCitation
|
HIV Vaccine Technology
|
|
gptkbp:profession
|
Scientist
|
|
gptkbp:publications
|
HIV Vaccine Development
|
|
gptkbp:researchAreas
|
Houghton_Lab
|
|
gptkbp:researchContribution
|
Vaccine Development Strategies
|
|
gptkbp:researchInterest
|
gptkb:Journal_of_Virology
gptkb:Nature_Reviews_Immunology
gptkb:Nature_Reviews_Drug_Discovery
gptkb:Nature_Reviews_Chemistry
gptkb:Frontiers_in_Microbiology
gptkb:Nature_Reviews_Earth_&_Environment
gptkb:Journal_of_Infectious_Diseases
gptkb:Nature_Reviews_Genetics
gptkb:Nature_Reviews_Molecular_Cell_Biology
gptkb:Nature_Reviews_Physics
Nature
Science
Vaccine
The Lancet
Nature Biotechnology
Clinical Infectious Diseases
Emerging Infectious Diseases
Nature Reviews Neuroscience
PLOS ONE
Nature Reviews Cancer
Nature Reviews Materials
Annual Review of Microbiology
Trends in Microbiology
NIH_Funding
Viral_Immunology
|